More articles from Article

You have access
Inhibition of the aromatase enzyme by exemestane cysteine conjugates
Irina Teslenko, Christy J.W. Watson, Gang Chen and Philip Lazarus

Molecular Pharmacology August 11, 2022, MOLPHARM-AR-2022-000545; DOI: https://doi.org/10.1124/molpharm.122.000545
You have access
Analgesic α-Conotoxin Binding Site on the Human GABA_B Receptor
Anuja R. Bony, Jeffrey R. McArthur, Akari Komori, Ann R. Wong, Andrew Hung and David J. Adams

Molecular Pharmacology August 9, 2022, MOLPHARM-AR-2022-000543; DOI: https://doi.org/10.1124/molpharm.122.000543
You have access
Upacicalcet is a novel secondary hyperparathyroidism drug that targets the amino acid binding site of calcium-sensing receptor
Hirofumi Sato, Sei Murakami, Yusuke Horii, Go Nishimura, Ryosuke Iwai, Moritaka Goto and Naoki Takahashi

Molecular Pharmacology August 5, 2022, MOLPHARM-AR-2022-000522; DOI: https://doi.org/10.1124/molpharm.122.000522
Open Access
Molecular and Functional Characterization of GABA Receptor Subunits GRD and LCCH3 from Human Louse Pediculus Humanus Humanus
Omar Hashim, Claude L. Charvet, Berthine Toubaté, Aimun A.E. Ahmed, Nicolas Lamassiaude, Cédric Neveu, Isabelle Dimier-Poisson, Françoise Debierre-Grockiego and Catherine Dupuy

Molecular Pharmacology August 2022, 102 (2) 116-127; DOI: https://doi.org/10.1124/molpharm.122.000499
You have access
Resveratrol Binds Nuclear Receptor 4A1 (NR4A1) and Acts as an NR4A1 Antagonist in Lung Cancer Cells
Lei Zhang, Greg Martin, Kumaravel Mohankumar, Joshua Trae Hampton, Wenshe Ray Liu and Stephen Safe

Molecular Pharmacology August 2022, 102 (2) 80-91; DOI: https://doi.org/10.1124/molpharm.121.000481
You have access
Lubiprostone is a Non-Selective Activator of cAMP-Gated Ion Channels and Chloride Channel Protein 2 (Clc-2) Has a Minor Role in its Prosecretory Effect in Intestinal Epithelial Cells
Apurva A. Oak, Tifany Chu, Pattareeya Yottasan, Parth D. Chhetri, Jie Zhu, J. Du Bois and Onur Cil

Molecular Pharmacology August 2022, 102 (2) 106-115; DOI: https://doi.org/10.1124/molpharm.122.000542
You have access
Effects of Inhibitors of SLC9A-Type Sodium-Proton Exchangers on Survival Motor Neuron 2 (SMN2) mRNA Splicing and Expression
Sambee Kanda, Emily Moulton and Matthew E.R. Butchbach

Molecular Pharmacology August 2022, 102 (2) 92-105; DOI: https://doi.org/10.1124/molpharm.122.000529
You have access
Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia
Sharan R. Srinivasan, Haoran Huang, Wei-Chih Chang, Joshua A. Nasburg, Hai M. Nguyen, Tim Strassmaier, Heike Wulff and Vikram G. Shakkottai

Molecular Pharmacology July 2022, 102 (1) 17-28; DOI: https://doi.org/10.1124/molpharm.121.000478
You have access
Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development
Carlos E. Sanz-Rodríguez, Benjamin Hoffman, Paul J. Guyett, Andrei Purmal, Baljinder Singh, Michael P. Pollastri and Kojo Mensa-Wilmot

Molecular Pharmacology July 2022, 102 (1) 1-16; DOI: https://doi.org/10.1124/molpharm.121.000430
You have access
GPR83 Engages Endogenous Peptides from Two Distinct Precursors to Elicit Differential Signaling
Seshat M. Mack, Ivone Gomes, Amanda K. Fakira, Mariana Lemos Duarte, Achla Gupta, Lloyd Fricker and Lakshmi A. Devi

Molecular Pharmacology July 2022, 102 (1) 29-38; DOI: https://doi.org/10.1124/molpharm.122.000487

Main menu

User menu

Search

More articles from Article

Pages

Navigate

More Information

ASPET's Other Journals